Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$770.00 1.12 (0.15%) as of 4:30 Fri 5/17


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 736.57(B)
Last Volume: 1,669,189 Avg Vol: 3,285,540
52 Week Range: $423.21 - $792.28
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 750 870,750 2,710,260 6,110,274
Total Sell Value $565,200 $608,250,580 $2,147,483,647 $2,147,483,647
Total People Sold 1 2 5 6
Total Sell Transactions 1 13 42 86
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 306
  Page 11 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Tai Jackson P Director   –       •      –    2021-11-15 4 A $258.43 $177,025 D/D 685 62,035     -
   Greene Gabrielle E Director   –       •      –    2021-11-15 4 A $258.43 $174,957 D/D 677 677     -
   Baicker Katherine Director   –       •      –    2021-11-15 4 A $258.43 $174,957 D/D 677 21,307     -
   Alvarez Ralph Director   –       •      –    2021-11-15 4 A $258.43 $185,811 D/D 719 50,878     -
   Walker Karen Director   –       •      –    2021-11-15 4 A $258.43 $174,957 D/D 677 4,950     -
   Lilly Endowment Inc 10% Owner   –       –       •   2021-11-04 4 S $266.29 $52,419,318 D/D (195,000) 107,853,610 -6%     
   Lilly Endowment Inc 10% Owner   –       –       •   2021-10-28 4 S $252.55 $45,236,369 D/D (178,631) 108,048,610 -5%     
   Lilly Endowment Inc 10% Owner   –       –       •   2021-10-27 4 S $252.33 $5,391,997 D/D (21,369) 108,227,241 -6%     
   Johnson Kimberly H Director   –       •      –    2021-10-18 4 A $238.98 $9,559 D/D 40 354     -
   Tai Jackson P Director   –       •      –    2021-10-18 4 A $238.98 $1,912 D/D 8 61,349     -
   Alvarez Ralph Director   –       •      –    2021-10-18 4 A $238.98 $10,993 D/D 46 50,159     -
   Tai Jackson P Director   –       •      –    2021-09-20 4 A $231.64 $2,085 D/D 9 61,341     -
   Johnson Kimberly H Director   –       •      –    2021-09-20 4 A $0.00 $0 D/D 42 314     -
   Alvarez Ralph Director   –       •      –    2021-09-20 4 A $231.64 $10,887 D/D 47 50,113     -
   Van Naarden Jacob SVP, CEO LoxoONC, Pres LlyONCO   •       –      –    2021-09-05 3 IO $0.00 $0 I/I 0 4,342 -3%     
   Van Naarden Jacob SVP, CEO LoxoONC, Pres LlyONCO   •       –      –    2021-09-05 3 IO $0.00 $0 D/D 0 4,692 -3%     
   Lilly Endowment Inc 10% Owner   –       –       •   2021-08-18 4 S $274.31 $4,232,603 D/D (15,430) 108,248,610 -4%     
   Lilly Endowment Inc 10% Owner   –       –       •   2021-08-17 4 S $274.08 $838,698 D/D (3,060) 108,264,040 -1%     
   Johnson Kimberly H Director   –       •      –    2021-08-16 4 A $269.94 $9,718 D/D 36 271     -
   Tai Jackson P Director   –       •      –    2021-08-16 4 A $269.94 $1,890 D/D 7 61,281     -
   Alvarez Ralph Director   –       •      –    2021-08-16 4 A $269.94 $10,798 D/D 40 49,889     -
   Lilly Endowment Inc 10% Owner   –       –       •   2021-08-09 4 S $264.81 $28,010,135 D/D (104,711) 108,267,100 -4%     
   Lilly Endowment Inc 10% Owner   –       –       •   2021-08-06 4 S $264.05 $2,005,965 D/D (7,597) 108,371,811 -4%     
   Lilly Endowment Inc 10% Owner   –       –       •   2021-08-05 4 S $264.23 $35,065,320 D/D (132,692) 108,379,408 6%     
   Lilly Endowment Inc 10% Owner   –       –       •   2021-08-04 4 S $260.19 $3,568,360 D/D (13,458) 108,512,100 5%     
  306 Records found
  Previous  10  11  12  13   
  Page 11 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us